<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2024.142014</article-id><article-id pub-id-type="publisher-id">OJNeph-132337</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Causes and Prognosis of Cases of Acute Obstructive Renal Failure Managed at the Donka National Hemodialysis Center
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Yaya Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Mouctar Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Dian Barry</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kadiatou</surname><given-names>Mamadou Bobo Barry</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saikou</surname><given-names>Oumar Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djenabou</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soriba</surname><given-names>Bangoura</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Malal Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Thierno</surname><given-names>Mamadou Oury Diallo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Lamine Kaba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alpha</surname><given-names>Oumar Bah</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Urology-Andrology, CHU Ignace Deen, Conakry, Guinea</addr-line></aff><aff id="aff2"><addr-line>Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of the Republic of Guinea, Conakry, Guinea</addr-line></aff><aff id="aff1"><addr-line>Department of Nephrology-Hemodialysis, CHU Donka, Conakry, Guinea</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>04</month><year>2024</year></pub-date><volume>14</volume><issue>02</issue><fpage>136</fpage><lpage>146</lpage><history><date date-type="received"><day>15,</day>	<month>December</month>	<year>2023</year></date><date date-type="rev-recd"><day>6,</day>	<month>April</month>	<year>2024</year>	</date><date date-type="accepted"><day>9,</day>	<month>April</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Introduction:</b> Acute obstructive renal failure (AORF) is a frequent clinical situation, secondary to obstruction of the urinary excretory tract. Whatever the cause, urinary tract obstruction suddenly opposes glomerular filtration and is responsible for tubulointerstitial lesions. It accounts for 10% of acute renal failure (ARF). The aim of this study was to identify the causes and prognosis of cases of acute obstructive renal failure managed at the Centre National d’h&#233;modialyse Donka. 
  <b>Material and Methods: </b>This was a prospective descriptive study lasting 6 months, from September 1, 2022 to February 29, 2023. All patients undergoing haemodialysis for acute obstructive renal failure who agreed to participate in the study and whose medical records were complete were included. 
  <b>Results: </b>During the course of the study, we registered 97 haemodialysis patients, including 20 cases (20.62%) of acute obstructive renal failure. The mean age of the patients was 57.8 &#177; 10.54 years, with a male predominance of 11 cases (55%) and a sex ratio of 1.22. The reasons for consultation were dominated by physical asthenia 11 cases (55%), lumbar pain 9 cases (50%), vomiting 6 cases (30%) and acute urine retention 6 cases (30%). Arterial hypertension 16 cases (80%) and urinary tract infection 10 cases (50%) were the most common antecedents. The etiologies of RAOI were dominated by lithiasis 10 cases (50%), neoplasia 6 cases (30%) and benign prostatic hypertrophy 3 cases (15%). mean creatinine was 1267.60 &#177; 710.76 μmol/l with extremes of 243 μmol/l and 2822 μmol/l, mean urea was 39.56 &#177; 18.36, hyperkalemia in 14 cases (70%) and hyponatremia in 8 cases (40%). After hemodialysis, 9 cases (45%) recovered renal function, 4 cases (20%) became chronic and 7 cases (35%) died. 
  <b>Conclusion:</b> The frequency of AKI remains non-negligible in our department, and early detection and prompt management would considerably reduce the morbidity and mortality associated with this pathology.
 
</p></abstract><kwd-group><kwd>Acute Obstructive Renal Failure</kwd><kwd> Hemodialysis</kwd><kwd> Prognosis</kwd><kwd> Donka</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute renal failure (ARF) is a syndrome characterized by a rapid fall in glomerular filtration rate over a period of hours or days, with the kidneys unable to eliminate the products of nitrogen metabolism and maintain homeostasis [<xref ref-type="bibr" rid="scirp.132337-ref1">1</xref>] .</p><p>Acute obstructive renal failure (AORF) is a frequent clinical situation, secondary to obstruction of the urinary excretory tract. Whatever the cause, urinary tract obstruction suddenly opposes glomerular filtration and is responsible for tubulointerstitial lesions. It accounts for 10% of the causes of ARF [<xref ref-type="bibr" rid="scirp.132337-ref2">2</xref>] . The presence of oligo-anuria is frequent, but not mandatory [<xref ref-type="bibr" rid="scirp.132337-ref3">3</xref>] .</p><p>Diagnosis of AKI is based on clinical, biological and imaging findings. Elevated urea and creatinine levels are synonymous with renal failure. The role of imaging is to confirm the obstructive origin of this renal failure and to establish the etiological diagnosis [<xref ref-type="bibr" rid="scirp.132337-ref4">4</xref>] .</p><p>The severity of ARF results mainly from the abolition of the kidney’s capacity to excrete sodium, leading to the risk of hydrosodium overload and acute pulmonary oedema (APO), and potassium, with the risk of threatening hyperkalaemia [<xref ref-type="bibr" rid="scirp.132337-ref4">4</xref>] .</p><p>Etiologies are dominated by excretory tract tumours, pelvic tumours, retroperitoneal fibrosis and urinary lithiasis [<xref ref-type="bibr" rid="scirp.132337-ref5">5</xref>] . Prolonged duration of obstruction is the main determinant of failure to recover renal function in the short and long term, and of the occurrence of Obstruction Lifting Syndrome (OLSS), requiring early diagnosis and prompt management [<xref ref-type="bibr" rid="scirp.132337-ref4">4</xref>] .</p><p>Management of IRAO consists in balancing metabolic disorders, and urinary drainage should be performed as a matter of urgency using a double-J catheter, percutaneous nephrostomy, cystostomy or simple bladder catheterization. Recourse to extra-renal purification is indicated in cases of hydrosodium overload, PAO or hyperkalemia threatening short-term vital prognosis [<xref ref-type="bibr" rid="scirp.132337-ref4">4</xref>] .</p><p>In Europe, ARI accounts for 5% of hospital admissions [<xref ref-type="bibr" rid="scirp.132337-ref6">6</xref>] .</p><p>In France, RAOI accounts for 10% of patients hospitalized for AKI and 17% of outpatients [<xref ref-type="bibr" rid="scirp.132337-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.132337-ref7">7</xref>] .</p><p>In Morocco, in 2016 Es-salmy A in his doctoral thesis in Medicine reported that IRAO represented 8 to 14% of ARI and 8% of patients had benefited from hemodialysis [<xref ref-type="bibr" rid="scirp.132337-ref8">8</xref>] .</p><p>In Senegal, in 2017 Zaynab A in her doctoral thesis in Medicine reported that out of 13 patients with RAOI one patient had benefited from hemodialysis [<xref ref-type="bibr" rid="scirp.132337-ref9">9</xref>] .</p><p>In Mali, in 2021 Sy S et al. noted that out of 1133 patients admitted for AKI, 83 (7.3%) had HAI, 18 of whom received hemodialysis [<xref ref-type="bibr" rid="scirp.132337-ref10">10</xref>] .</p><p>In Guinea, Bah MB et al. in 2018 collated 72 cases of RAOI in the Urology Department of the Ignace DEEN National Hospital; none received hemodialysis [<xref ref-type="bibr" rid="scirp.132337-ref11">11</xref>] . Diallo OP, in his doctoral thesis in Medicine in 2022, noted 26.5% of HAI in elderly patients presenting with HAI in the Nephrology Department of Conakry University Hospital [<xref ref-type="bibr" rid="scirp.132337-ref12">12</xref>] .</p><p>The aim of this study was to identify the causes and prognosis of HAI cases managed at the Donka National Hemodialysis Center.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>We conducted a prospective descriptive study lasting 6 months from September 1, 2022 to February 29, 2023.</p><p>Patients of either sex and of any age were included if they were diagnosed with RAOI and had at least a creatinine level, a renal or abdominal ultrasound scan, or a CT scan without contrast media injection.</p><p>Patients whose medical records were incomplete or unusable were not included.</p><p>Sampling:</p><p>We carried out an exhaustive census of all patients undergoing haemodialysis for HAI whose paraclinical workup was complete.</p><p>For data collection, we interviewed patients and collected data on a pre-established survey form.</p><p>Our variables were qualitative and quantitative:</p><p>Sociodemographic data: Prevalence, age, gender, occupation.</p><p>Clinical data:</p><p>Reasons for consultation: Asthenia, physical, back pain, vomiting, anuria, pollakiuria, urine retention, lower limb oedema.</p><p>Past history: Hypertension, diabetes, nephrotoxic drugs, benign prostatic hypertrophy, urinary tract lithiasis, malformative uropathies, urinary tract infections.</p><p>Etiologies of IRAO: Bilateral urinary tract lithiasis, urinary tract lithiasis on a single anatomical or functional kidney, prostate cancer, cervical cancer, benign prostatic hypertrophy and post-infectious urethral stricture.</p><p>Paraclinical data:</p><p>Complete blood count, creatininemia, urea, calcemia, kalemia, natraemia and Reno-vesico-prostatic ultrasound, Uroscanner.</p><p>Prognostic data: Length of hospital stay, recovery of renal function, progression to CKD death.</p><p>Data were collected using a pre-established survey form, then analyzed using EPI INFO 7.4.0 software.</p><p>Statistical analysis:</p><p>Data were collected using a survey form entered in Excel 2016 and analyzed using EPI INFO 7.4.0. Qualitative variables were expressed as percentages and quantitative variables as means and standard deviations.</p><p>Ethical consideration:</p><p>Ethical approval was obtained from the Chair of Nephrology at the Donka University Hospital. Medical confidentiality was preserved throughout our study, and the data collected were used anonymously.</p></sec><sec id="s3"><title>3. Result</title><p>Sociodemographic data:</p><p>During the course of the study, we registered 97 new haemodialysis patients, including 20 cases (20.62%) with acute obstructive renal failure. The mean age of patients was 57.8 &#177; 10.54 years, with a male predominance of 11 cases (55%) and a sex ratio of 1.22 (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic characteristics of patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Number N = 20</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Prevalence</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Obstructive ARF</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >20.62</td></tr><tr><td align="center" valign="middle" >Other causes of hemodialysis</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >79.38</td></tr><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >35 - 44</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >45 - 54</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >55 - 64</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >65 and over</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Average: 57.8 &#177; 10.54</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 35 &#224; 75</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >55</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Sex ratio = 1.22</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Profession</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Civil servant</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Merchant</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >House wife</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >35</td></tr></tbody></table></table-wrap><p>Clinical data:</p><p>Physical asthenia 11 cases (55%), lumbar pain 9 cases (50%), vomiting 6 cases (30%) and acute urine retention 6 cases (30%) were the most common reasons for consultation. The etiologies of RAOI were dominated by lithiasis (10 cases, 50%) and neoplasia (6 cases, 30%). Arterial hypertension was noted in 16 cases (80%) and urinary tract infection in 10 cases (50%) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Paraclinical data:</p><p>Mean creatinine was 1267.60 &#177; 710.76 &#181;mol/l with extremes of 243 &#181;mol/l and 2822 &#181;mol/l, mean urea was 39.56 &#177; 18.36 hyperkalemia 14 cases (70%) and hyponatremia in 8 cases (40%) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Prognostic data:</p><p>After hemodialysis, 9 cases (45%) recovered renal function, 4 cases (20%) became chronic and 7 cases (35%) died (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients with RAOI according to clinical data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Number N = 20</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Reasons for consultation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Physical asthenia</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >55</td></tr><tr><td align="center" valign="middle" >Lumbar pain</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Conjunctival pallor</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Anuria</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Oliguria</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Urinary retention</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Edema of the lower limbs</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Epigastralgia</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Dyspnea</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Hematuria</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Hiccups</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Dysuria</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Pollakiuria</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >History</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HTA</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >80</td></tr><tr><td align="center" valign="middle" >Urinary tract infection</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >Diabetes mellitus</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Malaria</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >HIV</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >NSAID use</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Transvesical adenomectomy of the prostate gland</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Peptic ulcer disease</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Pyelolithotomy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Etiology</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Bilateral ureteral lithiasis</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >80</td></tr><tr><td align="center" valign="middle" >Prostate cancer</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >66.67</td></tr><tr><td align="center" valign="middle" >Cervical cancer</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >33.33</td></tr><tr><td align="center" valign="middle" >Benign prostatic hyperplasia</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Ureteral lithiasis in a single anatomical kidney</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Ureteral lithiasis on functional single kidney</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients according to paraclinical data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Anemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mild Hb 110 - 119 g/dl</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Moderate Hb 80 - 109 g/dl</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Severe Hb &lt; 80 g/dl</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Normal Hb</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Hb Mean: 9.79 &#177; 2.26 g/dl</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 6.2 &#224; 14</td></tr><tr><td align="center" valign="middle" >Creatininemia (&#181;mol/l)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >243 - 500</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >501 - 1000</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >1001 - 1500</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >&gt;1500</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >35</td></tr><tr><td align="center" valign="middle" >Mean: 1267.60 &#177; 710.76 (&#181;mol/l)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 243 &#224; 2822</td></tr><tr><td align="center" valign="middle" >Urea (mmol/l)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >7.5 - 30</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >&gt; 30</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >Mean: 39.56 &#177; 18.36</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 13 &#224; 61.01</td></tr><tr><td align="center" valign="middle" >Kalemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypokalemia &lt; 3,5 mmol/l</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Hyperkalemia [threatening] &gt; 5 mmol/l</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >70</td></tr><tr><td align="center" valign="middle" >Mean: 6.27 &#177; 1.59 mmol/l</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 2.66 &#224; 9.66</td></tr><tr><td align="center" valign="middle" >Natraemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hyponatremia Na+ &lt; 135 mmol/l</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Normal Na+ 135 – 145 mmol/l</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >55</td></tr><tr><td align="center" valign="middle" >Hypernatremia Na+ &gt; 145 mmol/l</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Mean: 136.30 &#177; 11.07 mmol/l</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 115.00 &#224; 156.40</td></tr><tr><td align="center" valign="middle" >Calcemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypocalcemia (calcemia &lt; 2.2 mmol/l)</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >70</td></tr><tr><td align="center" valign="middle" >Normal (calcemia 2.20 - 2.60 mmol/l)</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Mean: 2.05 &#177; 0.28 mmol/l</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Extremes: 1.69 &#224; 2.60</td></tr><tr><td align="center" valign="middle" >Ultrasound</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Right kidney</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >65</td></tr><tr><td align="center" valign="middle" >Decreased</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Increased</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Left Kidney</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >63.16</td></tr><tr><td align="center" valign="middle" >Increased</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >26.32</td></tr><tr><td align="center" valign="middle" >Decreased</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10.53</td></tr><tr><td align="center" valign="middle" >Cortico-sinus differentiation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Preserved</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >Little preserved</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >35</td></tr><tr><td align="center" valign="middle" >Not preserved</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Echo-structure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Echogenic</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >90</td></tr><tr><td align="center" valign="middle" >Hyperechoic</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Hypoechoic</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Dilation of urinary tract</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hydronephrosis</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Uretero hydronephrosis</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >70</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to prognosis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Prognosis</th><th align="center" valign="middle" >Number N = 20</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Length of hospital stay (days)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4 - 9</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30.00</td></tr><tr><td align="center" valign="middle" >10 - 19</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >60.00</td></tr><tr><td align="center" valign="middle" >20 - 40</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10,00</td></tr><tr><td align="center" valign="middle" >Average: 13.65 &#177; 6.56</td><td align="center" valign="middle" >Extremes: 4.0 &#224; 30.00</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Causes of death</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Septic shock</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.85</td></tr><tr><td align="center" valign="middle" >Prostate cancer</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.28</td></tr><tr><td align="center" valign="middle" >Uremic coma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.28</td></tr><tr><td align="center" valign="middle" >Pulmonary embolism</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.28</td></tr><tr><td align="center" valign="middle" >Acute lung edema</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.28</td></tr><tr><td align="center" valign="middle" >Evolution of renal function</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Recovery of renal function</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >CKD</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >35</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>In the course of this study, we recorded 97 cases of renal failure from all causes, of which 20 cases (20.62%) underwent haemodialysis for acute obstructive renal failure. Our result is close to that of Sy S et al. in Mali in 2021, who found 22% cases of acute obstructive renal failure in their study [<xref ref-type="bibr" rid="scirp.132337-ref10">10</xref>] . On the other hand, our result is higher than that of Es-Salmy in Morocco in 2016 in his doctoral thesis in medicine had reported a frequency of (8%) [<xref ref-type="bibr" rid="scirp.132337-ref8">8</xref>] .</p><p>Male sex was the most represented 11 cases (55%) with a sex ratio of 1.22. This result corroborates that of Mabrouk K et al in Morocco in 2015, who found 57% male patients [<xref ref-type="bibr" rid="scirp.132337-ref13">13</xref>] .</p><p>The mean age of our patients was 57.8 &#177; 10.54 years. Our result differs from that reported by Fellah E et al in Tunisia in 2018 who found a mean age of 63.6 &#177; 15 years [<xref ref-type="bibr" rid="scirp.132337-ref14">14</xref>] .</p><p>Physical asthenia 11 cases (55%), back pain 9 cases (45%), anuria (40%) were the most frequent reasons for consultation. These results are similar to those reported by Demb&#233;l&#233; S in his medical doctorate thesis in Mali in 2008, who found a predominance of physical asthenia (73.9%), back pain and fever in 62.2% and 17.5% respectively [<xref ref-type="bibr" rid="scirp.132337-ref15">15</xref>] . This could be explained by the fact that lower back pain is one of the clinical manifestations of excretory tract obstruction during the course of the disease.</p><p>Arterial hypertension 16 cases (80%), urinary tract infection 10 cases (50%), diabetes 6 cases (30%) and HIV 3 cases (15%) were the antecedents found in our study. These results could be explained by the fact that, on the one hand, hypertension is a major risk factor for kidney disease and, on the other hand, the urinary tract infection encountered is merely the direct consequence of prolonged urinary stasis.</p><p>The etiology of acute obstructive renal failure was dominated by bilateral ureteral lithiasis in 8 cases (80%), prostate cancer in 4 cases (66.67%) and benign prostatic hypertrophy in 3 cases (15%).</p><p>Mean creatinine was 1267.60 &#177; 710.76 &#181;mol/l with extremes of 243 &#181;mol/l and 2822 &#181;mol/l, mean urea was 39.56 &#177; 18.36 mmol/l. This result is similar to that of Assal O et al. in Morocco in 2021, who found a mean creatinine level of 1256.7 &#177; 675.25 &#181;mol/l [<xref ref-type="bibr" rid="scirp.132337-ref16">16</xref>] . This rise in creatinemia could be related to a delay in diagnosis. Hyperkalemia was noted in 14 cases (70%). This may be explained by the fact that urinary tract obstruction plays an important role in the occurrence of hyperkalemia in renal failure. We recorded 8 cases (40%) of hyponatremia. This result could be explained by the occurrence of obstruction lifting syndrome in some of our patients.</p><p>Most of our patients were severely anemic, with 8 (40%) having hemoglobin levels below 8 g/dl. Anemia was moderate in 5 cases (25%). The mean hemoglobin level was 9.79 &#177; 2.26 g/dl; this result could be explained by the inflammatory syndrome due to infection, on the one hand, and by the fact that the kidneys participate in the production of red blood cells through the production of Erythropoietin, on the other.</p><p>Abdomino-pelvic ultrasonography was carried out in all patients, and we noted uretero-hydronephrosis in 14 cases (70%) and hydronephrosis in 6 cases (30%). We recorded 2 cases (10.53%) of diminished kidney size and 5 cases (26.32%) of increased kidney size.</p><p>The etiologies of RAOI were dominated by lithiasis in 10 cases (50%) and neoplasia in 6 cases (30%). Our data corroborate those of Assal O et al. in Morocco in 2021 [<xref ref-type="bibr" rid="scirp.132337-ref16">16</xref>] , but also those described in the literature [<xref ref-type="bibr" rid="scirp.132337-ref17">17</xref>] .</p><p>The average hospital stay was 13.65 &#177; 6.56 days, with extremes ranging from 4.0 to 30.00 days.</p><p>The evolution after hemodialysis was marked by 9 cases (45%) recovering renal function, 4 cases (20%) progressing to chronicity and 7 cases (35%) dying. This high mortality rate in our series could be explained by the associated cardiovascular comorbidities, which aggravate the vital prognosis, on the one hand, and by the delayed diagnosis and treatment of most of our patients, on the other.</p><p>The presumed cause of death was dominated by septic shock in 3 cases (42.85%), followed by pulmonary embolism and acute lung oedema in 1 case (14.28%) each.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Acute obstructive renal failure is a uro-nephrological emergency, and its prevalence remains frequent in our hospital center at 20.62%. The male sex was the most represented, the mean age was 57.8 &#177; 10.54 years. Clinical symptoms were dominated by physical asthenia, back pain, vomiting and acute urine retention. The etiologies of RAOI were dominated by lithiasis and neoplastic pathologies. Systematic screening and early management would considerably reduce the morbidity and mortality associated with this pathology.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our sincere thanks go to all the teachers, lecturers and people who, through their words, advice, writings and criticism through their words, advice, writings and criticism, guided my reflections and agreed to meet me and answer my questions during my research.</p></sec><sec id="s7"><title>What We Know about It</title><p>Acute obstructive renal failure is a medical and surgical emergency, and its diagnosis is based on clinical and para-clinical arguments. It is a major public health problem worldwide, and in Guinea in particular.</p>What Is New in Our Study<p>This study constitutes the first experience in our Donka hospital center, Out of 97 hemodialysis patients during our study, 20 cases (20.62%) were hemodialysed for acute obstructive renal failure.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>All authors participated in data collection, analysis and drafting of the manuscript.</p><p>The final manuscript was read and accepted by all authors.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s10"><title>Cite this paper</title><p>Diallo, A.Y., Diallo, M.M., Barry, M.D., Barry, K.M.B., Diallo, S.O., Diallo, D., Bangoura, S., Diallo, M.M., Diallo, T.M.O., Kaba, M.L. and Bah, A.O. (2024) Causes and Prognosis of Cases of Acute Obstructive Renal Failure Managed at the Donka National Hemodialysis Center. Open Journal of Nephrology, 14, 136-146. https://doi.org/10.4236/ojneph.2024.142014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.132337-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, I., Seck, S.M. and Diouf, B. (2017) Insuffisance r&amp;#233;nale aigu&amp;#235; du sujet &amp;#226;g&amp;#233; au centre hospitalier r&amp;#233;gional de Saint-Louis du S&amp;#233;n&amp;#233;gal. &lt;i&gt;N&amp;#233;phrologie&lt;/i&gt;&lt;i&gt; &amp; &lt;/i&gt;&lt;i&gt;Th&amp;#233;rapeut&lt;/i&gt;&lt;i&gt;i&lt;/i&gt;&lt;i&gt;que&lt;/i&gt;, 13, 361. &lt;br&gt;https://doi.org/10.1016/j.nephro.2017.08.219 </mixed-citation></ref><ref id="scirp.132337-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lanzy, A., Voumbo Matoumona, Y., Ondziel Opara, A., Niama, A., Banga Mouss, R., Ondongo Atipo, A., &lt;i&gt;et al&lt;/i&gt;. (2021) &amp;#201;pid&amp;#233;miologie et &amp;#201;tiologies de l&amp;#8217;Insuffisance R&amp;#233;nale Aigue Obstructive au Centre Hospitalier Universitaire de Brazzaville. &lt;i&gt;Health Sciences and Disease&lt;/i&gt;, 22, 98-102. </mixed-citation></ref><ref id="scirp.132337-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Meyer, R.D. (1986) Risk Factors and Comparisons of Clinical Nephrotoxicity of Amino Glycosides. &lt;i&gt;The American Journal of Medicine&lt;/i&gt;, 80, 119-125. &lt;br&gt;https://doi.org/10.1016/0002-9343(86)90489-4 </mixed-citation></ref><ref id="scirp.132337-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Guerrot, D. and Tamion, F. (2013) Insuffisance r&amp;#233;nale aigu&amp;#235; obstructive&amp;#8239;: Le point de vue du r&amp;#233;animateur.&lt;i&gt; &lt;/i&gt;&lt;i&gt;Progr&amp;#232;s&lt;/i&gt;&lt;i&gt; en &lt;/i&gt;&lt;i&gt;Urologie&lt;/i&gt;, 23, 19-22. &lt;br&gt;https://doi.org/10.1016/j.fpurol.2012.10.001 </mixed-citation></ref><ref id="scirp.132337-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Natchagande, G., Avakoudjo, J.D.G., Hounnasso, P.P., Sanni, R.T., Agounkpe, M.M., Gandaho, K.I., &lt;i&gt;et al&lt;/i&gt;. (2015) Insuffisance r&amp;#233;nale obstructive. Aspects &amp;#233;pid&amp;#233;miologiques et diagnostiques &amp;#224; propos de 51 cas au CNHU de Cotonou. &lt;i&gt;Black Africa&lt;/i&gt;, 62, 16-22. </mixed-citation></ref><ref id="scirp.132337-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Vinsonneau, C. (2003) Conduite diagnostique devant une insuffisance r&amp;#233;nale aigu&amp;#235;. In: Insuffisance r&amp;#233;nale aigu&amp;#235; en r&amp;#233;animation. Edition Elsevier Masson, 44-118.</mixed-citation></ref><ref id="scirp.132337-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">St&amp;#233;phan, H., Renaudin, P., Alain, R. and Paascale, S. (2018) Traitement de l&amp;#8217;insuffisance r&amp;#233;nale. &lt;i&gt;Pharmacie&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;clinique&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;et&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;th&amp;#233;rapeutique&lt;/i&gt;, 2018, 977-1021. &lt;br&gt;https://doi.org/10.1016/B978-2-294-75077-9.00055-4 </mixed-citation></ref><ref id="scirp.132337-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">ES-Salmy, A. (2016) L&amp;#8217;insuffisance r&amp;#233;nale aigue obstructive&amp;#8239;: &amp;#201;pid&amp;#233;miologie, aspects cliniques, &amp;#233;tiologiques, prise en charge et &amp;#233;volution (A propos de 100 cas). Master&amp;#8217;s Th&amp;#232;se, Universit&amp;#233; Sibi Mohammed Ben Abdellah, Fes. </mixed-citation></ref><ref id="scirp.132337-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Zaynab, A. (2017) Insuffisance r&amp;#233;nale aigue obstructive: Evaluation de la prise en charge. Master&amp;#8217;s Th&amp;#232;se, Universit&amp;#233; Cheikh Anta Diop, Dakar.  </mixed-citation></ref><ref id="scirp.132337-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sy, S., Samak&amp;#233;, M., Coulibaly, A.Z., Fofana, A.S., Diallo, D., Coulibaly, M., &lt;i&gt;et al&lt;/i&gt;. (2021) Aspects &amp;#233;pid&amp;#233;miologiques et pronostiques de l&amp;#8217;insuffisance renale obstructive dans le sevice de N&amp;#233;phrologie du CHU du point G, Bamako, Mali.</mixed-citation></ref><ref id="scirp.132337-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bah, M.B., Bah, I., Barry, M., Barry, M., Kant&amp;#233;, D., Mara, L., &lt;i&gt;et al&lt;/i&gt;. (2020) Insuffisance r&amp;#233;nale aigue obstructive: Aspects &amp;#233;pid&amp;#233;miocliniques et th&amp;#233;rapeutiques au service d&amp;#8217;urologie de l&amp;#8217;h&amp;#244;pital national Ignace Deen CHU de Conakry. &lt;i&gt;Journal of Afr&lt;/i&gt;&lt;i&gt;i&lt;/i&gt;&lt;i&gt;can Clinical Cases and Reviews&lt;/i&gt;, 4, 183-189. </mixed-citation></ref><ref id="scirp.132337-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, O.P. (2022) Insuffisance r&amp;#233;nale aigu&amp;#235; chez les sujets &amp;#226;g&amp;#233;s du service de n&amp;#233;phrologie de l&amp;#8217;h&amp;#244;pital Donka. Master&amp;#8217;s Th&amp;#232;se, Universit&amp;#233; Kofi Annan de Guin&amp;#233;, Conakry. </mixed-citation></ref><ref id="scirp.132337-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mabrouk, K., Izem, A., Amer, D., Mtioui, N., Elkhayatt, S., Zamd, M.,&lt;i&gt; et al&lt;/i&gt;. (2015) Anurie obstructive en h&amp;#233;modialyse urgente (&amp;#233;tude sur 5 ans). &lt;i&gt;N&amp;#233;phrologie&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;Th&amp;#233;r&lt;/i&gt;&lt;i&gt;a&lt;/i&gt;&lt;i&gt;peutique&lt;/i&gt;, 11, 318-319. &lt;br&gt;https://doi.org/10.1016/j.nephro.2015.07.145 </mixed-citation></ref><ref id="scirp.132337-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Felah, E., Barbouch, S., Amiri, L., Hajji Najjar, M., Harzallah, A., Aoudia, R., &lt;i&gt;et al&lt;/i&gt;. (2018) Insuffisance r&amp;#233;nale aigu&amp;#235; obstructive: &amp;#192; propos de 31 cas. &lt;i&gt;N&amp;#233;phrologie&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;Th&amp;#233;r&lt;/i&gt;&lt;i&gt;a&lt;/i&gt;&lt;i&gt;p&lt;/i&gt;&lt;i&gt;eutique&lt;/i&gt;, 14, 315-316. &lt;br&gt;https://doi.org/10.1016/j.nephro.2018.07.152  </mixed-citation></ref><ref id="scirp.132337-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">D&amp;#233;mb&amp;#233;l&amp;#233;, S. (2008) Pr&amp;#233;valence hospitali&amp;#232;re de l&amp;#8217;insuffisance r&amp;#233;nale aigue obstructive dans le service de n&amp;#233;phrologie et d&amp;#8217;h&amp;#233;modialyse du CHU de point. Master&amp;#8217;s Th&amp;#232;se, Universit&amp;#233; de Bamako, Bamako. </mixed-citation></ref><ref id="scirp.132337-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Assal, O., Driouch, L., Ouzeddoun, N., Bayahia, R. and Benamar, L. (2021) Apport de l&amp;#8217;h&amp;#233;modialyse dans l&amp;#8217;insuffisance r&amp;#233;nale aigue obstructive: B&amp;#233;n&amp;#233;fices et risques. &lt;i&gt;International Journal of Advanced Research&lt;/i&gt;, 9, 524-531. </mixed-citation></ref><ref id="scirp.132337-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Elouaer, Y., Guedri, Y., Troudi, M.R., Azzabi, A., Sahtout, W., Mrabet, S., &lt;i&gt;et al&lt;/i&gt;. (2019) L&amp;#8217;insuffisance r&amp;#233;nale aigu&amp;#235; prise en charge en h&amp;#233;modialyse: &amp;#192; propos de 230 cas. &lt;i&gt;N&amp;#233;phrologieTh&amp;#233;rapeutique&lt;/i&gt;, 15, 324. &lt;br&gt;https://doi.org/10.1016/j.nephro.2019.07.149</mixed-citation></ref></ref-list></back></article>